Technical Guidelines for Integrated Disease Surveillance ... - PHRplus

More documents

Recommendations

Info

C. Location of Lesion(s)19. Upper limbs: Right Left Lower limbs: Right Left Abdomen BackButtocks and perineum Thorax Head and neckD. Clinical Forms20. Active: Nodule Papule Plaque Oedema Ulcer OsteomyelitisInactive: Scar due to Buruli ulcer Amputation due to Buruli ulcerOthers, specify______________________________________________________21. Disability present upon presentation: N Y22. Date of clinical diagnosis(dd/mm/yy):___/___/___E. Confirmation of Clinical Diagnosis23. ZN staining Culture Histopathology PCRPos Neg ND Pos Neg ND Pos Neg ND Pos Neg NDIf positive, date: If positive, date: If positive, date: If positive, date:(dd/mm/yy) (dd/mm/yy) (dd/mm/yy) (dd/mm/yy)___/___/___ ___/___/___ ___/___/___ ___/___/___Pos = Positive Neg = Negative ND = Not doneF. Principal Treatment (s)24. Wound dressing only Excision only Excision + primary closureExcision + split skin graft Amputation HeatAntimycobacterial agents, specify:________________________________________________________Antibiotics and other drugs:_____________________________________________________________Others:_____________________________________________________________________________162Technical Guidelines for Integrated Disease Surveillance and Response in Ghana
G. Treatment Outcomes25. Healed without sequelaeHealed with sequelae, specify:_______________________________________________________Referral for treatment of active lesions: where__________________Date: (dd/mm/yy)___/___/___Absconded/discharged against medical adviceDied, Buruli ulcer related, specify:___________________________________________________Died, not related to Buruli ulcer, specify:______________________________________________H. Referral of Sequelae26. No: why not___________________________________________________________________Yes: where____________________________________________when (dd/mm/yy)___/___/____27. Date of Discharge (dd/mm/yy):___/___/___Annex 14: Case-based Surveillance Report Form for Buruli Ulcer (BU01)163
Page 3:
Technical Guidelines forIntegrated
Page 6 and 7:
3.3.1 Review the updated charts, ta
Page 8 and 9:
7.1.2 Monitor timeliness and comple
Page 10 and 11:
List of TablesTable 1: Surveillance
Page 13:
AcronymsAFROAFPAIDSCBSCBSWCDCDHMTE-
Page 18 and 19:
An ill person presents to medical a
Page 20 and 21:
How are surveillance functions desc
Page 22 and 23:
4.0 Investigate** 5.0 Respond 6.0 P
Page 24 and 25:
National4.0 Investigate** 5.0 Respo
Page 26 and 27:
In general, the health of Ghanaians
Page 28 and 29:
How does Ghana’s MOH/GHS support
Page 30 and 31:
1.0 Identify Cases of Priority Dise
Page 32 and 33:
1.2 Improve district procedures for
Page 35 and 36:
Section 2Report Priority Diseases a
Page 37 and 38:
Name of diseaseRoutine summary repo
Page 39 and 40:
Identify and train CBS volunteers o
Page 41:
Clinicians, ward nurses or other re
Page 44 and 45:
3.0 Analyse DataAnalysing trends of
Page 46 and 47:
3. Label all the rows and columns,
Page 48 and 49:
Figure 4: Meningitis cases from Bol
Page 50 and 51:
The first step in analysing data by
Page 52 and 53:
3.2.3.3 Calculate case fatality rat
Page 54 and 55:
Table 6: Alert and epidemic/action
Page 56 and 57:
3.4 Use the analysis results to imp
Page 58 and 59:
4.0 Investigate Reported Outbreaks
Page 60 and 61:
4.4 Prepare to conduct an investiga
Page 62 and 63:
Review laboratory results with the
Page 64 and 65:
Draw a histogram representing the c
Page 66 and 67:
If the shape of the curve suddenly
Page 68 and 69:
5.0 Prepare and Respond to Outbreak
Page 70 and 71:
Periodically review and update othe
Page 72 and 73:
3. Select appropriate communication
Page 74 and 75:
Improve safe disposal of human wast
Page 76 and 77:
Table 7: Daily water needs per pers
Page 78 and 79:
Recommendations for improving epide
Page 80 and 81:
6.0 Provide FeedbackData are report
Page 82 and 83:
The newsletter can be produced simp
Page 84 and 85:
7.0 Evaluate and Improve Surveillan
Page 86 and 87:
Table 8 lists possible indicators t
Page 88 and 89:
Priority diseases are recorded in t
Page 90 and 91:
Indicators for measuring quality of
Page 93 and 94:
Section 8Community-based Surveillan
Page 95 and 96:
members to take action in the event
Page 97 and 98:
Participate in information dissemin
Page 99 and 100:
Section 9Summary Guidelines for Spe
Page 101 and 102:
Analyse and interpretdataReferenceT
Page 103 and 104:
Buruli UlcerBackground Buruli ulce
Page 105 and 106:
Cholera may cause severe dehydratio
Page 107 and 108:
Respond to epidemicthresholdIf a su
Page 109 and 110:
In Ghana, the disease was endemic i
Page 111 and 112:
ReferenceA guide to eliminating lep
Page 113 and 114:
Promote environmental sanitation: c
Page 115 and 116:
Surveillance goal Use a rapid late
Page 117 and 118:
OnchocerciasisBackground Filarial
Page 119 and 120:
Poliomyelitis (Acute flaccid paraly
Page 122 and 123:
Public health action Conduct activ
Page 124 and 125:
The global HIV pandemic has been a
Page 126 and 127: Respond toepidemicAnalyse and inter
Page 128 and 129: Public health action Case finding
Page 131 and 132: Annex 1Using Assessment Results to
Page 133: Tally, compile and report summary t
Page 136 and 137: Diseases of special public health f
Page 138 and 139: Pneumonia in childrenless than 5 ye
Page 140 and 141: Other diseases of public health imp
Page 143 and 144: Annex 5Laboratory Tests for Confirm
Page 145 and 146: Suspected disease orconditionCholer
Page 147 and 148: Suspected disease orconditionDiagno
Page 153: Annex 6List of Laboratories for Con
Page 157 and 158: Annex 8Case-based Surveillance Repo
Page 159 and 160: If laboratory specimen collectedFor
Page 161: 16. When the investigation of the c
Page 164 and 165: (For reporting from health facility
Page 166 and 167: 13. For vaccine-preventable disease
Page 169 and 170: Annex 11Total Number of Patients Se
Page 171: Annex 12Year ___________ Quarter __
Page 174 and 175: Analysis, interpretations, comments
Page 179 and 180: Annex 15Monthly Registration of Bur
Page 181: Classification a Location of Lesion
Page 185: Annex 17Managing Public Health Surv
Page 189 and 190: Annex 19Sample Tables for Person An
Page 191 and 192: Annex 20Log of Suspected Outbreaks
Page 193: Instructions for filling suspected
Page 196 and 197: INITIAL CLINICAL HISTORYPlease use
Page 198 and 199: SPECIMEN COLLECTIONDate Sent toDate
Page 200 and 201: 186Technical Guidelines for Integra
Page 202 and 203: 188Technical Guidelines for Integra
Page 205 and 206: Annex 25Treat Cases During an Outbr
Page 207 and 208: Also give home-based fluids as foll
Page 209 and 210: 3. Give vitamin A to children with
Page 211: Annex 26Preparing Disinfectant Solu
Page 214 and 215: If the health facility does not kee
Page 216 and 217: Message:DO YOU PREPARE FOOD SAFELY?
Page 218 and 219: Reducing exposure to mosquitoesPERS
Page 221 and 222: Annex 30Estimating Vaccine Supplies
Page 223: Annex 31Recommended Immunization Pr
Page 226 and 227:
Lab analysis and results:With text,
Page 228 and 229:
District Epidemic Management Commit
Page 231 and 232:
Annex 35Checklist for Supervising S
Page 233 and 234:
Activity Supervisory Question Answe
Page 235 and 236:
Annex 36Indicators for Monitoring t
Page 238:
Partners for HealthReformplusU.S. A
show all

Technical Guidelines for Integrated Disease Surveillance ... - PHRplus

Create successful ePaper yourself

Delete template?

Save as template?